Currently Viewing:
Currently Reading
Surgical Site Infections Common After Gastrointestinal Surgeries Worldwide
February 18, 2018 – Kaitlynn Ely
USPSTF Recommends Against Screening for Ovarian Cancer in Asymptomatic Women
February 18, 2018 – Jaime Rosenberg
Study Finds Merkel Cell Carcinoma Incidence Has Increased Since 2000
February 17, 2018 – Kaitlynn Ely
New ECPR Protocol Shows Increase in Survival of Some Cardiac Arrest Patients
February 17, 2018 – Samantha DiGrande
Anthem Changes to ED Payment Policy Leaves Some Unsatisfied
February 16, 2018 – Allison Inserro
5 Things Being Discussed and Addressed in Healthcare Spending
February 16, 2018 – Jaime Rosenberg
This Week in Managed Care: February 16, 2018
February 16, 2018
AJMC® in the Press, February 16, 2018
February 16, 2018 – AJMC Staff
Survey Identifies Barriers to Achieving Value-Based Care Models
February 16, 2018 – Kaitlynn Ely

What We're Reading: Uterine Transplant Birth; Opioid Treatment; Curbing HIV

AJMC Staff
A woman gives birth after receivng a uterine transplant for the first time in the US; a once-monthly treatment for patients with poioid addiction gains FDA approval; and LA public health officials launch an initiative to reduce the annual number HIV infections.

First Baby Born in United States After Uterine Transplant

For the first time in the United States, a woman has delivered a baby following a uterine transplant, reported The New York Times. The mother, who was born without a uterus, received the transplant last year from a living donor at the Baylor University Medical Center in Dallas. The transplants are temporary, allowing a woman to have 1 or 2 children, and then are removed. Until now, all other births following uterine transplant occurred in Sweden, at the Sahlgrenska University Hospital in Gothenburg.

Once-Monthly Opioid Addiction Injection Gains US Approval

The first monthly treatment for addiction to opiates, Indivior Plc’s Sublocade, has been approved by the FDA, according to Bloomberg. The treatment is an injection of buprenorphine, a drug that weakens withdrawal symptoms in patients with addiction. Its infrequent dosing could help patients better adhere to the regimen compared with current treatments, said the FDA. The treatment will be available early next year, according to Indivior.

Los Angeles Officials Initiate Efforts to Curb HIV

With more than 600,000 people living with HIV in the county, Los Angeles public health officials have launched an effort to reduce the annual number of HIV infections, according to The Los Angeles Times. The officials have set their focus on reducing the annual HIV infections, increasing the proportion of people with HIV who are diagnosed, and increasing the proportion of the population who are virally suppressed. They plan to accomplish these goals through encouraging community health centers and private medical providers to focus on preventive care.

Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!